# Study of BMN 673, a PARP Inhibitor, in Healthy Adult Male Volunteers

> **NCT01776437** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 18 (actual)

## Conditions studied

- Human Volunteers

## Interventions

- **DRUG:** BMN 673

## Key facts

- **NCT ID:** NCT01776437
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02
- **Primary completion:** 2013-05
- **Final completion:** 2013-07
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2017-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01776437

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01776437, "Study of BMN 673, a PARP Inhibitor, in Healthy Adult Male Volunteers". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01776437. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*